Literature DB >> 31531847

TAM receptors attenuate murine NK-cell responses via E3 ubiquitin ligase Cbl-b.

Leilani M Chirino1, Suresh Kumar2, Mariko Okumura1, David E Sterner2, Michael Mattern2, Tauseef R Butt2, Taku Kambayashi1.   

Abstract

TAM receptors (Tyro3, Axl, and Mer) are receptor tyrosine kinases (RTKs) that are expressed by multiple immune cells including NK cells. Although RTKs typically enhance cellular functions, TAM receptor ligation blocks NK-cell activation. The mechanisms by which RTKs block NK-cell signaling downstream of activating receptors are unknown. In this report, we demonstrate that TAM receptors attenuate NK cell responses via the activity of E3 ubiquitin ligase Casitas B lineage lymphoma b (Cbl-b). Specifically, we show that Tyro3, Axl, and Mer phosphorylate Cbl-b, and Tyro3 ligation activates Cbl-b by phosphorylating tyrosine residues 133 and 363. Ligation of TAM receptors by their ligand Gas6 suppresses activating receptor-stimulated NK-cell functions such as IFN-γ production and degranulation, in a TAM receptor kinase- and Cbl-b-dependent manner. Moreover, Gas6 ligation induces the degradation of LAT1, a transmembrane adaptor protein required for NK cell activating receptor signaling, in WT but not in Cbl-b knock-out NK cells. Together, these results suggest that TAM receptors may attenuate NK-cell function by phosphorylating Cbl-b, which in turn dampens NK-cell activation signaling by promoting the degradation of LAT1. Our data therefore support a mechanism by which RTKs attenuate, rather than stimulate, signaling pathways via the activation of ubiquitin ligases.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cellular activation; Inhibitory receptors; NK cells; Signal transduction; TAM receptors

Mesh:

Substances:

Year:  2019        PMID: 31531847      PMCID: PMC7769591          DOI: 10.1002/eji.201948204

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

1.  Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.

Authors:  D Fang; H Y Wang; N Fang; Y Altman; C Elly; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

2.  Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.

Authors:  Q Lu; G Lemke
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

3.  Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases.

Authors:  Anouk Caraux; Qingxian Lu; Nadine Fernandez; Sylvain Riou; James P Di Santo; David H Raulet; Greg Lemke; Claude Roth
Journal:  Nat Immunol       Date:  2006-06-04       Impact factor: 25.606

4.  TAM receptors are pleiotropic inhibitors of the innate immune response.

Authors:  Carla V Rothlin; Sourav Ghosh; Elina I Zuniga; Michael B A Oldstone; Greg Lemke
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 5.  Phosphatidylserine recognition by phagocytes: a view to a kill.

Authors:  Yi Wu; Nitu Tibrewal; Raymond B Birge
Journal:  Trends Cell Biol       Date:  2006-03-10       Impact factor: 20.808

Review 6.  Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.

Authors:  M Lienhard Schmitz
Journal:  Sci Signal       Date:  2009-06-23       Impact factor: 8.192

7.  A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock.

Authors:  T D Camenisch; B H Koller; H S Earp; G K Matsushima
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

8.  Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation.

Authors:  Yun Xiao; Guilin Qiao; Juan Tang; Rong Tang; Hui Guo; Samantha Warwar; Wallace Y Langdon; Lijian Tao; Jian Zhang
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

Review 9.  Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.

Authors:  Christina Lutz-Nicoladoni; Dominik Wolf; Sieghart Sopper
Journal:  Front Oncol       Date:  2015-03-11       Impact factor: 6.244

10.  The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.

Authors:  Magdalena Paolino; Axel Choidas; Stephanie Wallner; Blanka Pranjic; Iris Uribesalgo; Stefanie Loeser; Amanda M Jamieson; Wallace Y Langdon; Fumiyo Ikeda; Juan Pablo Fededa; Shane J Cronin; Roberto Nitsch; Carsten Schultz-Fademrecht; Jan Eickhoff; Sascha Menninger; Anke Unger; Robert Torka; Thomas Gruber; Reinhard Hinterleitner; Gottfried Baier; Dominik Wolf; Axel Ullrich; Bert M Klebl; Josef M Penninger
Journal:  Nature       Date:  2014-02-19       Impact factor: 49.962

View more
  7 in total

Review 1.  The expanding role for small molecules in immuno-oncology.

Authors:  Rienk Offringa; Lisa Kötzner; Bayard Huck; Klaus Urbahns
Journal:  Nat Rev Drug Discov       Date:  2022-08-18       Impact factor: 112.288

Review 2.  E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.

Authors:  D Jafari; M J Mousavi; S Keshavarz Shahbaz; L Jafarzadeh; S Tahmasebi; J Spoor; A Esmaeilzadeh
Journal:  Clin Exp Immunol       Date:  2021-01-10       Impact factor: 5.732

Review 3.  Natural Killer Cells: Tumor Surveillance and Signaling.

Authors:  Lizeth G Meza Guzman; Narelle Keating; Sandra E Nicholson
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

4.  Arrested development: suppression of NK cell function in the tumor microenvironment.

Authors:  Luke Riggan; Siya Shah; Timothy E O'Sullivan
Journal:  Clin Transl Immunology       Date:  2021-01-10

Review 5.  Targeting ubiquitin signaling for cancer immunotherapy.

Authors:  Xiaofei Zhou; Shao-Cong Sun
Journal:  Signal Transduct Target Ther       Date:  2021-01-13

6.  GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells.

Authors:  Andrea Kosta; Abdelilah Mekhloufi; Lorenzo Lucantonio; Alessandra Zingoni; Alessandra Soriani; Marco Cippitelli; Angela Gismondi; Francesca Fazio; Maria Teresa Petrucci; Angela Santoni; Helena Stabile; Cinzia Fionda
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 7.  Role of Vitamin K-Dependent Factors Protein S and GAS6 and TAM Receptors in SARS-CoV-2 Infection and COVID-19-Associated Immunothrombosis.

Authors:  Anna Tutusaus; Montserrat Marí; José T Ortiz-Pérez; Gerry A F Nicolaes; Albert Morales; Pablo García de Frutos
Journal:  Cells       Date:  2020-09-28       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.